Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: the last 12 patent decisions reviewed by the Supreme have been reversed, vacated

" Lincoln & Swartz are still listed as assignees even though the Master Agreement specified that they were to file a release. As I have been told before, it is of no concern that a specific release was not filed as it is spelled out in the MA."

This actually concerns me IMMENSELY.

Why wouldn't PTSC have immediately filed to correct the Patent ownnership, and why/how did Lincoln/Swartz get assigned in the first place? If the first MA was nullified or changed surely there is a responsibility on PTSC management to accurately record details relating to its primary asset.

And, heavens forbid, what if the recent Settlement changed the assignee to TPL? How would we ever know this? Is this why the PTSC BOD refuses to publish the 'new' MA and other related documentation?

How does one ask the Patent Office to investigate?


Share
New Message
Please login to post a reply